share_log

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

Twist Bioscience发布乐观业绩,周一与特斯拉、Amylyx Pharmaceuticals、regenxbio及其他大型股票一起走高
Benzinga ·  11/18 09:59

U.S. stocks were mixed, with the Dow Jones index falling around 80 points on Monday.

美国股市涨跌互现,道琼斯指数周一下跌约80点。

Shares of Twist Bioscience Corporation (NASDAQ:TWST) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter EPS and sales.

Twist Bioscience Corporation(纳斯达克股票代码:TWST)的股价在周一的交易中大幅上涨,此前该公司公布的第四季度每股收益和销售额好于预期。

Twist Bioscience reported a quarterly loss of 59 cents per share which beat the analyst consensus estimate of a loss of 70 cents per share. The company reported quarterly sales of $84.71 million which beat the analyst consensus estimate of $82.20 million.

Twist Bioscience公布的季度每股亏损为59美分,超过了分析师共识估计的每股亏损70美分。该公司公布的季度销售额为8,471万美元,超过了分析师共识估计的8,220万美元。

Twist Bioscience shares jumped 10.7% to $40.86 on Monday.

Twist Bioscience股价周一上涨10.7%,至40.86美元

Here are some other big stocks recording gains in today's session.

以下是今天交易日其他一些上涨的大型股票。

  • WeRide Inc. (NASDAQ:WRD) shares gained 19% to $20.67.
  • Super Micro Computer, Inc. (NASDAQ:SMCI) shares surged 19% to $22.12. This surge comes as the company faces potential delisting from the Nasdaq Stock Market.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) shares climbed 17% to $5.56 after Baird upgraded the stock from Neutral to Outperform and raised its price target from $3 to $11.
  • REGENXBIO Inc. (NASDAQ:RGNX) shares climbed 17% to $11.30 after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
  • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 16.2% to $37.41.
  • Semler Scientific, Inc. (NASDAQ:SMLR) shares rose 14.6% to $51.00. Semler Scientific announced it acquired 215 bitcoins for $17.7 million in cash, at an average price of $82,502 per bitcoin, inclusive of fees and expenses, during the period between Nov. 6 and Nov. 15.
  • Red Cat Holdings, Inc. (NASDAQ:RCAT) rose 14% to $5.36.
  • REGENXBIO Inc. (NASDAQ:RGNX) gained 13.2% to $10.90 after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
  • Mobileye Global Inc. (NASDAQ:MBLY) rose 8.1% to $16.20.
  • Zeta Global Holdings Corp. (NYSE:ZETA) shares rose 7.4% to $18.90. Zeta Global said David A. Steinberg, Zeta's Co-Founder, Chairman and CEO, members of the Company's leadership, and members of the Board of Directors intend to purchase shares of Zeta's Class A common stock on Monday.
  • Aurora Innovation, Inc. (NASDAQ:AUR) gained 7.2% to $5.35.
  • IAMGOLD Corporation (NYSE:IAG) rose 6.8% to $5.28.
  • Tesla, Inc. (NASDAQ:TSLA) shares gained 6.1% to $340.21 following reports of President-elect Donald Trump's policy outlook on regulations for autonomous driving.
  • NIO Inc. (NYSE:NIO) rose 4% to $4.6650.
  • WeRide Inc.(纳斯达克股票代码:WRD)股价上涨19%,至20.67美元。
  • 超级微电脑公司(纳斯达克股票代码:SMCI)股价飙升19%,至22.12美元。这种激增是在该公司可能面临从纳斯达克股票市场退市之际发生的。
  • Amylyx 制药公司(纳斯达克股票代码:AMLX)股价上涨17%,至5.56美元,此前贝尔德将该股从中性上调至跑赢大盘,并将目标股价从3美元上调至11美元。
  • REGENXBIO Inc.(纳斯达克股票代码:RGNX)股价上涨17%,至11.30美元,此前该公司宣布在杜兴氏基因疗法的关键试验中为第一位患者服药。
  • Destiny Tech100 Inc.(纳斯达克股票代码:DXYZ)股价上涨16.2%,至37.41美元。
  • 塞姆勒科学公司(纳斯达克股票代码:SMLR)股价上涨14.6%,至51.00美元。塞姆勒科学宣布,在11月6日至11月15日期间,它以1770万美元的现金收购了215枚比特币,平均价格为每比特币82,502美元,包括费用和开支。
  • 红猫控股公司(纳斯达克股票代码:RCAT)上涨14%,至5.36美元。
  • REGENXBIO Inc.(纳斯达克股票代码:RGNX)上涨13.2%,至10.90美元,此前该公司宣布在杜兴氏基因疗法的关键试验中为第一位患者服药。
  • Mobileye Global Inc.(纳斯达克股票代码:MBLY)上涨8.1%,至16.20美元。
  • 泽塔环球控股公司(纽约证券交易所代码:ZETA)股价上涨7.4%,至18.90美元。Zeta Global表示,Zeta的联合创始人、董事长兼首席执行官、公司领导层成员和董事会成员戴维·斯坦伯格打算在周一购买Zeta的A类普通股。
  • 奥罗拉创新公司(纳斯达克股票代码:AUR)上涨7.2%,至5.35美元。
  • IAMGOLD Corporation(纽约证券交易所代码:IAG)上涨6.8%,至5.28美元。
  • 特斯拉公司(纳斯达克股票代码:TSLA)股价上涨6.1%,至340.21美元,此前有报道称当选总统唐纳德·特朗普对自动驾驶监管的政策展望。
  • 蔚来公司(纽约证券交易所代码:NIO)上涨4%,至4.6650美元。

Now Read This:

现在阅读这篇文章:

  • Jim Cramer: Super Group Finally 'Broke Out,' This Basic Materials Stock Is 'Very Hard To Own Here'
  • 吉姆·克莱默:超级集团终于 “爆发” 了,这只基础材料股 “在这里很难拥有”
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发